PHAT Latest Press Releases

-- November 4, 2026 --

Phathom Pharmaceuticals to Participate in November Investor Conferences Globe Newswire 8:00 AM

-- November 3, 2026 --

Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA (vonoprazan) Tablets Exclusively at BlinkRx Globe Newswire 8:00 AM

-- October 29, 2026 --

Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- October 26, 2026 --

Phathom Pharmaceuticals Provides Update on FDA Litigation Globe Newswire 4:00 AM

-- October 23, 2026 --

Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA Globe Newswire 4:00 AM

-- October 19, 2026 --

Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026 Globe Newswire 8:00 AM

-- October 12, 2026 --

Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA (vonoprazan) at ACG 2026 Globe Newswire 8:00 AM

-- October 8, 2026 --

Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting Globe Newswire 8:00 AM

-- September 29, 2026 --

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA (vonoprazan) for As-Needed Treatment of Non-Erosive GERD Globe Newswire 8:00 AM

-- September 16, 2026 --

PHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law Business Wire 7:44 PM

-- September 1, 2026 --

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 4, 2026 --

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Phathom Pharmaceuticals, Inc. (PHAT) Globe Newswire 10:09 AM

-- August 3, 2026 --

PHAT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Phathom Pharmaceuticals, Inc. (PHAT) Business Wire 10:07 AM

-- July 31, 2026 --

PHAT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Phathom Pharmaceuticals PRNewswire 10:07 AM

-- July 30, 2026 --

Phathom Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Phathom Pharmaceuticals (PHAT) PRNewswire 5:35 PM

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 6:59 AM

-- July 20, 2026 --

Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026 Globe Newswire 8:00 AM

-- June 23, 2026 --

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA (vonoprazan) in Eosinophilic Esophagitis (EoE) Globe Newswire 7:59 AM

Market Data Delayed 15 Minutes